Get the Weekly Intelligence Brief — top committee picks every Sunday.

LQDA vs TXG

Liquidia Corporation vs 10x Genomics, Inc. — AI-powered side-by-side comparison
LQDA
Liquidia Corporation
68
Buy
VS
TXG
10x Genomics, Inc.
53
Watch
MetricLQDATXG
AI Score 68 53
Price $88.09 $58.48
P/E Ratio 368.26× -99.12×
ROE -154.0% -5.5%
Revenue Growth YoY
Gross Margin 91.8% 70.0%
Debt / Equity 1.70× 0.10×
Dividend Yield 0.0% 0.0%
RSI (14) 55.0 79.3
Beta 0.572 2.039
Expected Upside

AI Committee View

Current Innellis committee reasoning for LQDA versus TXG.
LQDA leads by 15 points.

LQDA scores 68/100 (Buy) versus TXG at 53/100 (Watch).

LQDA Committee View
67% agreement
6 analysts

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull Case
  • ROE of 46.8% shows genuine earnings power backing the valuation — Value
  • Revenue growing 1936.7% YoY -- genuine top-line momentum — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • P/E of 362.9 is expensive by classic value standards — Value
  • Price-to-book of 12.9x prices in significant intangible value — Value
  • MACD histogram negative -- bearish momentum — Technical
TXG Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -4.3% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
  • ROE of only -9.3% -- cheap may mean cheap for a reason — Value
  • Revenue declining -4.3% YoY -- this is not a growth story right now — Growth
  • RSI at 79 is in overbought territory — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
LQDA Full Analysis TXG Full Analysis